Literature DB >> 24399495

Non-anesthesiologist administrated propofol (NAAP) during endoscopic submucosal dissection for elderly patients with early gastric cancer.

Takuji Gotoda1, Chika Kusano, Masaya Nonaka, Masakatsu Fukuzawa, Shin Kono, Sho Suzuki, Takemasa Sato, Yuichiro Tsuji, Takao Itoi, Fuminori Moriyasu.   

Abstract

BACKGROUND: Propofol is rapidly increasing in use in many countries because endoscopists and patients report greater satisfaction with propofol than with conventional sedatives. However, propofol infusion during lengthy endoscopic procedures in elderly patients is still controversial. We investigated the safety of gastroenterologist-guided propofol sedation in elderly patients who underwent gastric endoscopic submucosal dissection (ESD) at a single center.
METHODS: We reviewed 121 medical records of patients who underwent gastric ESD. We compared retrospectively the details of propofol usage, hemodynamics, and re-sedation in the elderly group to those in a younger group.
RESULTS: No significant differences in patients' baseline characteristic including ASA classification between elderly and younger groups were shown. The average maintenance dose and total dose of propofol infusion could be similarly administrated in both groups. Seven adverse events (5.8 %) occurred at the time of propofol bolus injection. Although 3 cases (2.5 %) of hypotension (systolic blood pressure <80 mmHg), 8 cases (6.6 %) of desaturation (blood oxygen saturation <90 %) and 1 case (0.8 %) of bradycardia (pulse rate <40) were found during the maintenance of propofol infusion, there were no statistically significant differences in the elderly and younger groups. All events were immediately resolved without any intervention. No patients developed a re-sedated condition.
CONCLUSION: Gastroenterologist-guided propofol sedation during gastric ESD may be acceptable even in the elderly with ASA classification I/II under careful monitoring of vital signs and oxygen saturation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24399495     DOI: 10.1007/s10120-013-0336-9

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  27 in total

1.  Practice guidelines for sedation and analgesia by non-anesthesiologists.

Authors: 
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

2.  Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis.

Authors:  Mohammed A Qadeer; John J Vargo; Farah Khandwala; Rocio Lopez; Gregory Zuccaro
Journal:  Clin Gastroenterol Hepatol       Date:  2005-11       Impact factor: 11.382

3.  Safety of continuous propofol sedation for endoscopic procedures in elderly patients.

Authors:  J F Martínez; J R Aparicio; L Compañy; F Ruiz; L Gómez-Escolar; I Mozas; J A Casellas
Journal:  Rev Esp Enferm Dig       Date:  2011-02       Impact factor: 2.086

4.  Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy.

Authors:  Douglas K Rex; Ludwig T Heuss; John A Walker; Rong Qi
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

5.  Endoscopic sedation in the United States: results from a nationwide survey.

Authors:  Lawrence B Cohen; Julie S Wecsler; John N Gaetano; Ariel A Benson; Kenneth M Miller; Valerie Durkalski; James Aisenberg
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

6.  Should elderly patients undergo additional surgery after non-curative endoscopic resection for early gastric cancer? Long-term comparative outcomes.

Authors:  Chika Kusano; Motoki Iwasaki; Tonya Kaltenbach; Abby Conlin; Ichiro Oda; Takuji Gotoda
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

7.  Effects of aging on sensitivity of the pharyngeal and supraglottic areas.

Authors:  J E Aviv
Journal:  Am J Med       Date:  1997-11-24       Impact factor: 4.965

8.  Natural history of early gastric cancer: a non-concurrent, long term, follow up study.

Authors:  H Tsukuma; A Oshima; H Narahara; T Morii
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 9.  Endoscopist-directed administration of propofol: a worldwide safety experience.

Authors:  Douglas K Rex; Viju P Deenadayalu; Emely Eid; Thomas F Imperiale; John A Walker; Kuldip Sandhu; Anthony C Clarke; Lybus C Hillman; Akira Horiuchi; Lawrence B Cohen; Ludwig T Heuss; Shajan Peter; Christoph Beglinger; James A Sinnott; Thomas Welton; Magdy Rofail; Iyad Subei; Rodger Sleven; Paul Jordan; John Goff; Patrick D Gerstenberger; Harold Munnings; Martin Tagle; Brian W Sipe; Till Wehrmann; Jack A Di Palma; Kaitlin E Occhipinti; Egidio Barbi; Andrea Riphaus; Stephen T Amann; Gen Tohda; Timothy McClellan; Charles Thueson; John Morse; Nizam Meah
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

10.  Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients.

Authors:  Astrid Kerker; Christian Hardt; Hans-Eugen Schlief; Franz Ludwig Dumoulin
Journal:  BMC Gastroenterol       Date:  2010-01-27       Impact factor: 3.067

View more
  8 in total

1.  Safety of Target-Controlled Propofol Infusion by Gastroenterologists in Patients Undergoing Endoscopic Resection.

Authors:  Seung In Seo; Ji Yon Ryu; Sang Soo Kang; Jin Seo Lee; Hyoung Su Kim; Myoung Kuk Jang; Hak Yang Kim; Woon Geon Shin
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

Review 2.  Updated evidence on endoscopic resection of early gastric cancer from Japan.

Authors:  Mitsuhiro Fujishiro; Shuntaro Yoshida; Rie Matsuda; Akiko Narita; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Gastric Cancer       Date:  2016-10-04       Impact factor: 7.370

3.  The usage of overtube has a favorable effect on endoscopic submucosal dissection.

Authors:  Fatih Aslan; Ali Rıza Seren; Zehra Akpinar; Aylin Cakir Guven; Nese Ekinci; Emrah Alper; Cem Cekic; Belkis Unsal; Hironori Yamamoto
Journal:  Surg Endosc       Date:  2014-11-27       Impact factor: 4.584

4.  A target-controlled infusion system with bispectral index monitoring of propofol sedation during endoscopic submucosal dissection.

Authors:  Atsushi Imagawa; Hidenori Hata; Morihito Nakatsu; Akihiro Matsumi; Eijiro Ueta; Kozue Suto; Hiroyuki Terasawa; Hiroyuki Sakae; Keiko Takeuchi; Manabu Fujihara; Hitomi Endo; Hisae Yasuhara; Shinichi Ishihara; Hiromitsu Kanzaki; Hideki Jinno; Hidenori Kamada; Eisuke Kaji; Akio Moriya; Masaharu Ando
Journal:  Endosc Int Open       Date:  2014-11-17

5.  Feasibility of non-anesthesiologist-administered propofol sedation for emergency endoscopic retrograde cholangiopancreatography.

Authors:  Nobuhito Ikeuchi; Takao Itoi; Takuji Gotoda; Chika Kusano; Shin Kono; Kentaro Kamada; Takayoshi Tsuchiya; Naoyuki Tominaga; Shuntaro Mukai; Fuminori Moriyasu
Journal:  Gastroenterol Res Pract       Date:  2015-03-29       Impact factor: 2.260

6.  Comparison of sedation between the endoscopy room and operation room during endoscopic submucosal dissection for neoplasms in the upper gastrointestinal tract.

Authors:  Daisuke Yamaguchi; Naoko Yamaguchi; Yuki Takeuchi; Takahiro Yukimoto; Kei Ikeda; Kosuke Matsumoto; Rikako Kinoshita; Saori Kamachi; Kyosuke Sugiyama; Tomohito Morisaki; Keisuke Ario; Hisako Yoshida; Ryo Katsuki; Seiji Tsunada; Kazuma Fujimoto
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

7.  Safety and Efficacy of Nonanesthesiologist-Administrated Propofol during Endoscopic Submucosal Dissection of Gastric Epithelial Tumors.

Authors:  Keiichiro Abe; Keiichi Tominaga; Akira Kanamori; Tsunehiro Suzuki; Hitoshi Kino; Masakazu Nakano; Takeshi Sugaya; Kouhei Tsuchida; Yuichi Majima; Toshimitsu Murohisa; Makoto Iijima; Kenichi Goda; Atsushi Irisawa
Journal:  Gastroenterol Res Pract       Date:  2019-01-10       Impact factor: 2.260

8.  Clinical Outcomes and Complications of Endoscopic Submucosal Dissection for Superficial Gastric Neoplasms in the Elderly.

Authors:  Tsung-Chieh Yang; Ming-Chih Hou; Ping-Hsien Chen; I-Fang Hsin; Liang-Kung Chen; Mei-Yung Tsou; Han-Chieh Lin; Fa-Yauh Lee
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.